Industry News

The Centre for Process Innovation (CPI) began construction in October of 2020 on the Medicines Manufacturing Innovation Centre in Inchinnan in the United Kingdom. Created in collaboration with the University of Strathclyde, GSK, and AstraZeneca, the £42 million facility will enable the development of new pharmaceutical production methods that will be proven at scale in a GMP environment.

Lincoln Property Company is creating a mixed-use campus in Lexington, Mass. Designed by DiMella Shaffer, the development will include a laboratory building providing 95,000 sf of Class A research space linked by a central promenade to a 125,000-sf office facility. Strategically sited in the burgeoning life sciences district along the Route 128 corridor, the complex will include a community hub with a café to encourage interaction and collaboration between tenants, as well as a 502-space parking garage.

Florida Institute of Technology broke ground in October of 2020 on the $18 million Health Sciences Research Center in Melbourne, Fla. Enabling the university to expand its biomedical engineering and premedical programs, the 61,000-sf facility will feature a sophisticated anatomy lab with virtual dissection tables, an imaging suite with florescent and laser scanning microscopes, and labs for orthopedic research, tissue engineering, and computer modeling and simulation.

The University of Texas at El Paso opened the $93.5 million Interdisciplinary Research Building in September of 2020. Designed by Perkins+Will, the 156,000-sf project provides collaborative research labs, a vivarium, imaging suites, core labs, a visualization suite, conference rooms, an atrium, an auditorium, and academic and administrative offices. Housing teams from multiple departments, the flexible facility can be easily adapted to accommodate changing program requirements.

Merck is constructing a $69 million facility for the production of high-potency active pharmaceutical ingredient (HPAPI) and antibody-drug conjugate (ADC) compounds. Representing an expansion of the company's existing campus near Madison, the 70,000-sf structure will feature containment environments specifically designed for the manufacture of substances with single-digit nanogram occupational exposure limits. The building will allow the large-scale production of increasingly potent compounds for the creation of innovative cancer therapeutics.